Clinical Holds in Early Oncology Drug Development
View ORCID ProfileAlexandra Snyder, Dinesh De Alwis, Asthika Goonewardene, Priti S. Hegde
doi: https://doi.org/10.1101/2022.06.03.22275971
Alexandra Snyder
1Two River, Inc. 689 Fifth Ave, New York, NY 10022
MDDinesh De Alwis
3Early Oncology Development, Merck & Co., Inc., Rahway, NJ, USA
PhDAsthika Goonewardene
2Truist Securities. 711 Fifth Ave, New York, NY 10022
Priti S. Hegde
4Foundation Medicine. 150 Second Street, Cambridge, MA 02141
PhD
Article usage
Posted June 06, 2022.
Clinical Holds in Early Oncology Drug Development
Alexandra Snyder, Dinesh De Alwis, Asthika Goonewardene, Priti S. Hegde
medRxiv 2022.06.03.22275971; doi: https://doi.org/10.1101/2022.06.03.22275971
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)